Brainstorm Cell Therapeutics's market cap is currently $12.49M. The company's EPS TTM is $-3.492; its P/E ratio is ―; Brainstorm Cell Therapeutics is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.38. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ -366.00K
Gross Profit	$ -265.00K	$ -285.00K	$ -260.00K	$ -219.00K	$ -732.00K
Operating Income	$ -21.44M	$ -24.82M	$ -24.54M	$ -31.68M	$ -23.00M
EBITDA	$ -16.93M	$ -23.99M	$ -24.28M	$ -31.46M	$ -23.09M
Net Income	$ -17.19M	$ -23.73M	$ -24.38M	$ -31.94M	$ -23.50M
Balance Sheet
Cash & Short-Term Investments	$ 1.30M	$ 2.98M	$ 22.09M	$ 41.94M	$ 569.00K
Total Assets	$ 4.21M	$ 8.45M	$ 29.28M	$ 51.26M	$ 6.53M
Total Debt	$ 672.00K	$ 4.09M	$ 5.08M	$ 7.22M	$ 2.37M
Net Debt	$ -628.00K	$ 3.32M	$ -13.78M	$ -30.61M	$ 1.83M
Total Liabilities	$ 9.07M	$ 11.47M	$ 9.94M	$ 15.79M	$ 18.76M
Stockholders' Equity	$ -4.86M	$ -3.02M	$ 19.34M	$ 35.46M	$ -12.22M
Cash Flow
Free Cash Flow	$ -20.48K	$ -19.35M	$ -26.59M	$ -35.57M	$ -11.72M
Operating Cash Flow	$ -20.46M	$ -19.32M	$ -26.27M	$ -35.19M	$ -11.25M
Investing Cash Flow	$ 2.19M	$ 998.00K	$ 323.00K	$ -4.45M	$ 5.62M
Financing Cash Flow	$ 18.98M	$ 238.00K	$ 6.97M	$ 76.94M	$ 5.22M

Currency in USD

Brainstorm Cell Therapeutics Earnings and Revenue History

Income Statement >

Brainstorm Cell Therapeutics Debt to Assets

Balance Sheet >

Brainstorm Cell Therapeutics Cash Flow

Cash Flow >

Brainstorm Cell Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing